Collaborative effects of multiple bacterial strains in the gut may help prevent onset of certain inflammatory diseases

September 27, 2013
Figure 1: Inflammatory damage to the intestinal epithelium in a mouse model of colitis (left) is greatly reduced after oral administration of a mixture of 17 Clostridia strains (right). Credit: 2013 K. Atarashi et al.

At first, it may sound alarming to learn that a population of bacteria in your gut is conspiring to suppress your immune system—however, this is actually good news. By identifying the strains responsible, a research team led by Kenya Honda of the RIKEN Center for Integrative Medical Sciences may have uncovered a promising avenue of treatment for certain inflammatory disorders.

Immune cells known as regulatory T (Treg) cells are in part responsible for preventing the immune system from overreacting to foreign molecules or attacking healthy tissue. It is well established that immune function is affected by the diverse microbial community within the digestive tract, and Honda's team previously discovered that bacteria belonging to the genus Clostridium act on this particular immune pathway in mice to exert a strong anti-inflammatory effect.

"We showed that they were responsible for triggering production of Treg cells in the colon of mice," says Honda, "and that oral administration of these strains protected mice against colitis and systemic allergic responses."

Honda and his colleagues have now verified the existence of an equivalent in humans. They obtained a from a healthy volunteer and subjected it to the same purification regimen that yielded the Clostridia subpopulation identified in mice. When these bacteria were transplanted into the colons of 'germ-free' mice, in which the normal population of is entirely absent, they exerted a potent immunomodulatory effect. Through of this microbial cohort, the researchers zoomed in on a specific subset of 17 distinct Clostridia strains.

These strains collectively secrete a host of signaling molecules that promote Treg cell activation. "None of the organisms alone were nearly as potent as when they were in consortium," says Honda. "This suggests that cooperation between the strains is essential to their therapeutic effects." The collective benefit also appears to pertain to humans; analysis of the gut 'microbiome' in healthy patients versus individuals with ulcerative colitis revealed that all 17 strains were present at significantly lower levels in the latter group.

Accordingly, oral administration of this 17-microbe 'cocktail' greatly mitigated intestinal inflammation in mouse models of allergic diarrhea and ulcerative colitis (Fig. 1), suggesting the potential for a more 'natural' treatment of such conditions in humans. "A substantial number of patients don't benefit from existing drugs, which also have considerable adverse effects," says Honda. "We want to clinically test our hypothesis that reconstituting these bacteria to normal levels in patients may help restore immune tolerance and resolve chronic inflammatory processes."

Explore further: Mucus might prove useful in treating IBD, ulcerative colitis and Crohn's disease

More information: Atarashi, K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236 (2013). dx.doi.org/10.1038/nature12331

Related Stories

Mucus might prove useful in treating IBD, ulcerative colitis and Crohn's disease

September 26, 2013
Imagine mucus—which most people find unpleasant—actually helping your body maintain its equilibrium, prevent inflammation, and reduce food allergy problems.

Breast is best: Good bacteria arrive from mum's gut via breast milk

August 21, 2013
Scientists have discovered that important 'good' bacteria arrive in babies' digestive systems from their mother's gut via breast milk.

Genetically engineered bacteria could help in Crohn's and colitis

November 2, 2012
(Medical Xpress)—A new study in mice has shown that genetically engineered bacteria can protect against inflammatory bowel disease (IBD), which includes a host of conditions including ulcerative colitis and Crohn's disease.

Females fend off gut diseases

June 11, 2013
At least among mice, females have innate protection from certain digestive conditions, according to a new Michigan State University study.

Team explores the effects of exercise on ulcerative colitis

July 2, 2013
Aerobic exercise can lessen – or worsen – the symptoms of inflammatory bowel diseases such as ulcerative colitis, depending on the circumstances under which the exercise is undertaken, researchers report.

Recommended for you

New insights into protein's role in inflammatory response

July 28, 2017
A protein called POP2 inhibits a key inflammatory pathway, calming the body's inflammatory response before it can become destructive, Northwestern Medicine scientists have demonstrated in mouse models.

Targeting 'broken' metabolism in immune cells reduces inflammatory disease

July 12, 2017
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune ...

A perturbed skin microbiome can be 'contagious' and promote inflammation, study finds

June 29, 2017
Even in healthy individuals, the skin plays host to a menagerie of bacteria, fungi and viruses. Growing scientific evidence suggests that this lively community, collectively known as the skin microbiome, serves an important ...

Inflammatory bowel disease: Scientists zoom in on genetic culprits

June 28, 2017
Scientists have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease. The team from the Wellcome Trust Sanger Institute and their collaborators ...

Trials show unique stem cells a potential asthma treatment

June 28, 2017
A study led by scientists at Monash University has shown that a new therapy developed through stem cell technology holds promise as a treatment for chronic asthma.

Researchers find piece in inflammatory disease puzzle

May 23, 2017
Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.